<DOC>
	<DOCNO>NCT00581035</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity concomitant Prevenar Meningitec compare Prevenar alone Meningitec alone use part routine vaccination series healthy infant</brief_summary>
	<brief_title>Study Evaluating Safety Ability Produce Immune Response Prevenar Meningitec Given Same Time</brief_title>
	<detailed_description />
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy infant age 6 9 week</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>63 Days</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Meningococcal disease</keyword>
	<keyword>pneumococcal disease</keyword>
	<keyword>meningitis</keyword>
</DOC>